intestin
pig
harbor
mass
microorgan
essenti
intestin
homeostasi
host
health
intestin
microbi
disord
induc
enter
inflamm
metabol
dysfunct
therebi
caus
advers
effect
growth
health
pig
human
medicin
fecal
microbiota
transplant
fmt
engraft
fecal
microbiota
healthi
donor
patient
recipi
shown
efficaci
intestin
microbiota
restor
addit
use
wide
therapi
human
gastrointestin
diseas
includ
clostridium
difficil
infect
inflammatori
bowel
diseas
irrit
bowel
syndrom
given
pig
share
mani
similar
human
term
anatomi
nutrit
physiolog
intestin
microbi
composit
fmt
may
also
use
restor
normal
intestin
microbiota
pig
howev
feasibl
procedur
perform
fmt
pig
remain
unclear
summar
standard
prepar
fmt
pig
combin
standard
methodolog
human
fmt
pig
product
key
issu
includ
donor
select
fecal
materi
prepar
fecal
materi
transfer
stool
bank
establish
safeti
porcin
fmt
optim
donor
select
ensur
efficaci
porcin
fmt
reduc
risk
transmit
infecti
diseas
recipi
fmt
prepar
fresh
fecal
materi
highli
recommend
altern
frozen
fecal
suspens
also
prepar
optim
choic
conveni
similar
efficaci
oral
administr
fecal
suspens
could
optim
method
porcin
fecal
materi
transfer
furthermor
dilut
ratio
fecal
materi
frequenc
fecal
materi
transfer
could
adjust
accord
practic
situat
pig
industri
meet
potenti
largescal
requir
pig
industri
import
establish
stool
bank
make
porcin
fmt
readili
avail
futur
studi
also
focu
provid
robust
safeti
data
fmt
improv
safeti
toler
recipi
pig
standard
prepar
porcin
fmt
facilit
develop
microbi
target
therapi
improv
intestin
health
pig
frontier
microbiolog
wwwfrontiersinorg
frontier
microbiolog
wwwfrontiersinorg
mammalian
intestin
harbor
trillion
microb
includ
bacteria
fungi
virus
microb
play
vital
role
mainten
gut
homeostasi
host
health
sommer
backh
current
gut
microb
regard
microbi
organ
function
nutrient
absorpt
metabol
backh
et
al
host
immun
system
develop
ivanov
et
al
intestin
epithelium
differenti
sommer
backh
intestin
mucos
barrier
mainten
garrett
et
al
mammal
howev
sever
factor
includ
host
genet
characterist
diet
environ
antibiot
use
may
affect
intestin
microbi
divers
function
will
et
al
schroeder
backh
intestin
microbiota
disord
caus
host
gastrointestin
nongastrointestin
diseas
brandt
inflammatori
bowel
diseas
ibd
irrit
bowel
syndrom
ib
metabol
syndrom
borodi
khorut
current
antibiot
play
import
role
intestin
diseas
prevent
howev
antibioticsinduc
resist
spread
antibioticresist
pathogen
emerg
seriou
problem
worldwid
allen
et
al
antibiot
therapi
may
also
alter
intestin
microbi
commun
lead
intestin
microbi
dysbiosi
although
probiot
benign
microb
shown
efficaci
improv
host
intestin
health
efficaci
may
weak
probiot
microbi
composit
simpl
exogen
microb
may
colon
persist
adapt
dynam
intestin
homeostat
environ
tannock
et
al
sartor
focu
novel
fecal
microbiota
transplant
fmt
prevent
treatment
intestin
disord
increas
human
medicin
smit
et
al
clinic
applic
fmt
provid
convinc
proof
modif
intestin
microbiota
effect
therapi
intestin
dysbiosisrel
diseas
sekirov
finlay
smit
et
al
urgent
need
altern
therapi
antibiot
therapeut
potenti
intestin
microbi
manipul
promot
develop
fmt
hamilton
et
al
fecal
microbiota
transplant
refer
engraft
fecal
suspens
healthi
donor
recipi
intestin
tract
restor
commun
function
intestin
microbiota
khorut
sadowski
first
use
donor
fece
therapeut
agent
food
poison
diarrhea
record
handbook
emerg
medicin
chines
hong
ge
th
centuri
drew
th
centuri
shizhen
li
describ
effect
treatment
mani
intestin
diseas
fecal
materi
compendium
materia
medica
fecal
suspens
call
huanglong
tang
zhang
et
al
fmt
appli
veterinari
medicin
treat
intestin
disord
rumin
equin
sinc
th
centuri
borodi
et
al
human
medicin
fmt
firstli
use
treat
pseudomembran
enterocol
perform
eiseman
et
al
present
fmt
highli
recogn
effect
treatment
option
recurr
clostridium
difficil
infect
cdi
human
gradual
use
therapi
diseas
includ
ibd
ib
intract
constip
intestin
immunodefici
human
van
nood
et
al
borodi
et
al
repres
case
fmt
mammal
shown
tabl
anderson
et
al
ridaura
et
al
van
nood
et
al
sivan
et
al
diao
et
al
xiao
et
al
grow
evid
reveal
similar
intestin
microbiota
recipi
donor
well
normal
gut
microbi
composit
function
recipi
fmt
therapi
human
khorut
et
al
li
et
al
rather
continu
disturb
composit
normal
intestin
microbiota
fmt
effici
restor
gut
microbiota
recipi
current
pig
encount
multipl
stressor
overus
antibiot
campbel
et
al
barton
destroy
normal
commun
structur
intestin
microbiota
lead
emerg
multidrugresist
microorgan
intestin
laxminarayan
et
al
xu
et
al
use
antibiot
livestock
farm
gradual
ban
casewel
et
al
due
antibioticsinduc
resist
spread
antibioticresist
pathogen
antibiot
residu
food
emerg
seriou
problem
worldwid
allen
et
al
thu
find
altern
antibiot
import
livestock
farm
food
safeti
similar
human
be
pig
term
intestin
microbiota
nutrit
physiolog
garthoff
et
al
heinritz
et
al
fmt
may
promis
method
intestin
microbiota
reconstitut
health
improv
pig
howev
feasibl
procedur
perform
fmt
pig
remain
unclear
studi
summar
standard
prepar
porcin
fmt
use
pig
industri
prevent
treat
intestin
disord
optim
donor
select
ensur
efficaci
porcin
fmt
reduc
risk
transmit
infecti
diseas
transfer
fecal
suspens
select
donor
fit
may
advers
effect
stabil
toler
intestin
microbiota
therebi
caus
intestin
reject
importantli
porcin
fmt
may
lead
pathogen
transmiss
donor
fece
may
carri
pathogen
condit
pathogen
microb
thu
potenti
donor
select
use
strict
exclus
criteria
includ
genet
background
phenotyp
characterist
infecti
diseas
common
pathogen
indic
propos
standard
donor
screen
porcin
fmt
base
studi
relat
human
donor
screen
pig
product
studi
reveal
maternallin
firstdegre
rel
intim
contact
eg
mate
commonbond
share
environment
risk
factor
owen
et
al
immedi
famili
member
may
contain
mass
microbi
speci
gastrointestin
tract
result
recipi
toler
gut
microbiota
donor
immedi
famili
member
kelli
et
al
intestin
microbi
commun
recogn
potenti
associ
pathogenesi
diseas
intestin
disord
obes
twin
lean
twin
ridaura
et
al
germfre
mice
oral
gavag
transfer
characterist
donor
obes
human
mice
yorkshir
pig
tibetan
pig
rongchang
pig
diao
et
al
germfre
mice
oral
gavag
transfer
gut
characterist
pig
mice
yorkshir
tibetan
pig
xiao
et
al
commerci
hybrid
newborn
piglet
oral
gavag
improv
intestin
antiinflammatori
function
bakken
et
al
phenotyp
featur
behavior
intuit
reflect
health
statu
pig
addit
import
verifi
whether
histori
genet
diseas
base
genet
spectrum
analysi
ancestor
potenti
donor
moreov
potenti
risk
transmit
infecti
diseas
assess
importantli
donor
pig
candid
isol
pig
avoid
transmiss
pathogen
among
individu
exclus
criteria
detail
box
ensur
donor
safeti
porcin
fmt
serolog
test
stool
test
perform
monitor
infecti
pathogen
risk
factor
tabl
common
infecti
diseasesrel
pathogen
pig
industri
follow
meuren
et
al
denner
mueller
lee
renukaradhya
et
al
hu
et
al
serolog
test
wide
use
detect
infecti
diseasesassoci
pathogen
base
antigenantibodi
bind
reaction
vitro
use
antigenantibodi
bind
reaction
monitor
invas
pathogen
could
stimul
host
gener
correspond
antibodi
serum
blood
sampl
obtain
porcin
blood
vessel
coagul
c
serum
final
collect
supernat
coagul
blood
sampl
centrifug
serolog
test
mainli
includ
serum
neutral
test
hemagglutin
inhibit
test
enzymelink
immunosorb
assay
elisa
agar
diffus
test
complement
fixat
test
specif
elisa
test
power
approach
detect
infecti
diseasesassoci
pathogen
serolog
test
sever
advantag
includ
good
sensit
specif
sattler
et
al
shin
et
al
given
fece
may
carri
infecti
pathogen
stool
test
donor
pig
crucial
reduc
infecti
risk
porcin
fmt
directli
extract
fecal
dna
donor
pig
perform
pcr
amplif
reaction
box
key
issu
criteria
donor
screen
porcin
fmt
age
month
prefer
normal
bodi
temperatur
c
rectal
temperatur
ad
libitum
access
feed
water
normal
behavior
characterist
includ
breath
statu
feed
behavior
excret
behavior
social
behavior
reproduct
behavior
confirm
whether
correspond
pathogen
present
fece
borewicz
et
al
rnaviru
pathogen
could
detect
use
combin
method
fecal
rna
extract
revers
transcriptionpolymeras
chain
reaction
rtpcr
specif
primer
design
accord
gene
sequenc
standard
pathogen
whether
potenti
pathogen
present
fece
could
judg
correspond
amplifi
product
moreov
elisa
test
could
also
use
detect
pathogensassoci
antigen
fece
directli
confirm
whether
correspond
pathogen
porcin
epidem
diarrhea
viru
present
fece
opriessnig
et
al
recent
studi
use
fmt
restor
phenotyp
donor
recipi
suggest
key
role
intestin
microbiota
mammalian
host
health
obes
ridaura
et
al
goodrich
et
al
colon
cancer
wong
et
al
pathogen
resist
lawley
et
al
antitumor
immun
sivan
et
al
thu
crucial
select
optim
pig
donor
fecal
microbiota
composit
donor
may
critic
effect
efficaci
porcin
fmt
grow
evid
suggest
intestin
microbiotamedi
colon
resist
intestin
pathogen
buffi
pamer
sever
studi
reveal
probiot
includ
lactobacillu
bifidobacterium
bacillu
spp
contribut
decreas
level
colon
enterotoxigen
e
coli
etec
maintain
intestin
microbi
balanc
konstantinov
et
al
chiang
et
al
recent
studi
show
lactobacillu
johnsonii
may
potenti
efficaci
reduc
salmonella
invas
intestin
epithelium
pig
casey
et
al
thu
select
optim
donor
pig
highabund
function
microb
accord
result
fecal
microbi
composit
function
analyz
rdna
sequenc
metagenom
porcin
fmt
previou
studi
suggest
least
g
fecal
materi
use
fmt
human
mattila
et
al
satokari
et
al
howev
varieti
stool
diluent
steril
salin
nacl
phosphat
buffer
solut
pb
gough
et
al
brandt
aroniadi
use
altern
stool
materi
dilut
time
larg
volum
solvent
buffer
solut
cammarota
et
al
consid
heterogen
fecal
microb
differ
individu
donor
smit
et
al
suggest
dilut
ratio
fecal
materi
could
adjust
porcin
fmt
importantli
equip
use
fecal
suspens
prepar
strictli
steril
fresh
fece
use
porcin
fmt
transport
ice
special
laboratori
within
h
defec
lee
et
al
approxim
g
fecal
sampl
dilut
ml
steril
salin
homogen
standard
blender
slurri
filter
three
time
gauz
mattila
et
al
strainer
mm
stainless
steel
siev
elimin
undigest
small
particul
matter
fecal
suspens
owen
et
al
suggest
fecal
suspens
could
centrifug
g
min
hamilton
et
al
precipit
without
supernat
resuspend
fresh
steril
salin
result
suspens
transfer
recipi
directli
hamilton
et
al
fecal
microb
predominantli
anaerob
reduc
time
oxygen
exposur
fecal
materi
prepar
crucial
ensur
fecal
microbi
viabil
fecal
materi
prepar
process
carri
room
temperatur
c
prefer
anaerob
incub
rossen
et
al
figur
prepar
frozen
fecal
suspens
optim
choic
ensur
sampl
avail
whenev
need
porcin
fmt
cammarota
et
al
compar
studi
demonstr
frozen
fecal
materi
simplifi
practic
step
clinic
human
fmt
also
similar
efficaci
fresh
fecal
materi
satokari
et
al
improv
fecal
microbi
surviv
rate
cryopreserv
fresh
stool
sampl
dilut
steril
salin
homogen
filter
use
protocol
use
prepar
fresh
fecal
materi
porcin
fmt
subsequ
result
suspens
ad
glycerol
get
final
concentr
lee
et
al
final
fecal
suspens
label
accur
store
c
satokari
et
al
importantli
frozen
fecal
materi
store
low
temperatur
soon
possibl
c
refriger
liquid
nitrogen
ensur
fecal
microbi
surviv
need
porcin
fmt
frozen
fecal
suspens
thaw
c
water
bath
figur
upon
frozen
fecal
suspens
figur
schemat
workflow
fecal
microbiota
transplant
fmt
pig
first
optim
donor
select
ensur
efficaci
porcin
fmt
reduc
risk
transmit
infecti
diseas
transfer
fecal
suspens
via
strict
genet
background
investig
phenotyp
characterist
serolog
test
stool
test
fresh
fece
healthi
donor
pig
homogen
steril
salin
nacl
blender
stool
materi
dilut
time
larg
volum
buffer
solut
slurri
filter
steril
siev
suspens
either
transfer
recipi
mix
steril
glycerol
store
c
immedi
need
porcin
fmt
frozen
fecal
suspens
thaw
c
water
bath
frontier
microbiolog
wwwfrontiersinorg
thaw
steril
salin
solut
ad
obtain
requir
concentr
infus
fecal
suspens
implement
soon
possibl
room
temperatur
satokari
et
al
human
medicin
differ
rout
fecal
materi
transfer
report
includ
upper
gastrointestin
tract
oral
administr
middl
gastrointestin
tract
endoscopi
nasogastr
tube
nasal
jejunum
nasal
duodenum
lower
gastrointestin
tract
colonoscopi
enema
drekonja
et
al
mice
model
oral
gavag
cohous
use
transfer
fecal
microbiota
donor
mice
recipi
mice
will
et
al
cohous
take
advantag
natur
tendenc
mice
feed
fece
litterm
endt
et
al
recent
studi
suggest
porcin
fmt
via
oral
gavag
use
fecal
suspens
donor
pig
improv
growth
perform
intestin
barrier
innat
immun
function
recipi
pig
hu
et
al
xiao
et
al
howev
recent
studi
shown
porcin
fmt
via
oral
gavag
neg
effect
growth
perform
pig
mccormack
et
al
consid
practic
fecal
materi
transfer
pig
product
propos
oral
administr
fecal
suspens
could
optim
method
fecal
materi
transfer
porcin
fmt
figur
moreov
prepar
fecal
materi
could
mix
diet
direct
feed
formul
multilay
capsul
administr
diet
oral
gavag
directli
hirsch
et
al
youngster
et
al
frequenc
fecal
materi
transfer
could
also
adjust
accord
practic
situat
pig
industri
transfer
fecal
materi
perform
soon
possibl
microbi
cell
fragil
sensit
human
medicin
patient
cdi
treat
vancomycin
least
day
discontinu
antibiot
h
fmt
order
inhibit
abund
c
difficil
intestin
reduc
load
intestin
microb
hamilton
et
al
cammarota
et
al
howev
recent
studi
fmt
anim
model
shown
antibiot
pretreat
could
reduc
divers
nativ
microbiota
may
benefici
establish
exogen
microbiota
manichanh
et
al
thu
suggest
recipi
pig
nt
receiv
antibiot
week
fmt
free
water
diet
meet
potenti
largescal
requir
pig
industri
import
establish
stool
bank
make
porcin
fmt
readili
avail
fecal
donor
need
recruit
beforehand
rigor
screen
systemat
porcin
fmt
sever
key
issu
consid
first
strict
screen
donor
includ
stool
serolog
test
essenti
prevent
transfer
infecti
pathogen
reduc
risk
suscept
recipi
smith
et
al
addit
suppli
donor
fece
must
meet
grow
demand
thu
suggest
donor
pig
segreg
pig
sinc
stool
serolog
test
conduct
seri
stool
serolog
test
fece
continu
collect
elig
donor
pig
kazerouni
et
al
fecal
materi
prepar
transplant
mix
steril
glycerol
store
c
within
month
without
diminish
therapeut
efficaci
costello
et
al
establish
stool
bank
save
time
fmt
also
reduc
cost
sinc
singl
excel
donor
serv
multipl
recipi
hamilton
et
al
furthermor
stool
bank
retain
inform
donor
therebi
ensur
traceabl
fmt
therapeut
process
terveer
et
al
procedur
stool
bank
must
compli
basic
safeti
rule
thu
establish
stool
bank
may
optim
practic
procedur
porcin
fmt
facilit
develop
therapeut
method
current
clinic
experi
focus
use
fmt
human
shown
fmt
safe
human
patient
treat
fmt
experi
seriou
advers
event
borodi
khorut
except
minor
symptom
slight
diarrhea
constip
vomit
abdomin
discomfort
kump
et
al
rossen
et
al
report
common
advers
event
fmt
treatment
cdi
ibd
includ
diarrhea
abdomin
distent
abdomin
cramp
constip
fever
human
medicin
cui
et
al
agraw
et
al
patient
receiv
fmt
treatment
may
suffer
diarrhea
day
transplant
diarrhea
gener
disappear
short
term
human
medicin
advers
event
often
associ
method
use
deliv
fecal
materi
underli
diseas
physic
condit
patient
sokol
et
al
howev
evid
safeti
fmt
pig
rel
limit
porcin
fmt
appli
larg
longterm
compar
trial
conduct
assess
safeti
although
recent
studi
report
fecal
microb
donor
extens
colon
recipi
coexist
intestin
microb
recipi
month
human
medicin
li
et
al
effect
fecal
metabolit
heterogen
substanc
intestin
microbiota
recipi
still
unclear
consid
pork
main
meat
food
human
care
reflect
potenti
effect
porcin
fmt
pork
food
safeti
firstli
strict
donor
screen
essenti
reduc
risk
pathogen
transmiss
porcin
fmt
importantli
potenti
antibiot
drug
residu
pork
recipi
pig
avoid
via
strict
donor
select
donor
pig
histori
use
antibiot
drug
diet
inject
use
moreov
potenti
effect
fecal
metabolit
heterogen
substanc
pork
safeti
also
investig
porcin
fmt
base
fmt
procedur
human
medicin
pig
industri
propos
standard
prepar
includ
donor
select
fecal
materi
prepar
fecal
materi
transfer
porcin
fmt
use
pig
product
standard
prepar
porcin
fmt
increas
feasibl
clinic
oper
fmt
improv
intestin
health
pig
consid
intestin
microbiota
piglet
may
immatur
sensit
intestin
microenviron
conclud
porcin
fmt
piglet
product
stage
may
effect
crucial
select
optim
pig
donor
fecal
microb
donor
may
confer
efficaci
porcin
fmt
transfer
fecal
materi
may
increas
risk
infecti
pathogen
transmiss
grow
evid
link
longterm
diet
habit
composit
fecal
microbiota
matijas
et
al
ensur
fecal
microb
donor
pig
adapt
intestin
microenviron
recipi
pig
suggest
diet
formul
accord
nrc
requir
donor
pig
recipi
pig
donor
pig
recipi
pig
breed
known
us
differ
pig
breed
diet
differ
nutrient
requir
consid
diet
requir
donor
recipi
human
fmt
suggest
diet
formul
accord
nutrient
requir
differ
pig
breed
respect
although
relev
studi
evalu
surviv
rate
fecal
microb
includ
facult
anaerob
microb
strict
anaerob
microb
aerob
microb
expos
atmospher
condit
yamashiro
process
fecal
materi
prepar
directli
affect
efficaci
porcin
fmt
thu
import
shorten
time
fecal
materi
prepar
transfer
soon
possibl
porcin
fmt
consid
effect
fecal
metabolit
heterogen
substanc
intestin
microbiota
recipi
still
unclear
improv
effici
fecal
materi
purif
besid
method
filtrat
centrifug
maxim
potenti
porcin
fmt
method
fecal
materi
transfer
may
also
affect
efficaci
porcin
fmt
microb
belong
phylum
firmicut
form
spore
requir
growth
factor
upper
digest
tract
surviv
burn
et
al
addit
microb
belong
phylum
bacteroidet
may
denatur
acid
environ
stomach
transfer
damman
et
al
therefor
crucial
identifi
function
microbiota
choos
optim
method
deliveri
recent
report
shown
fecal
microbi
composit
recipi
highli
similar
donor
day
posttransplant
human
fmt
khorut
et
al
still
difficult
conclud
effect
fmt
visibl
long
effect
fmt
last
purpos
experiment
condit
porcin
fmt
may
differ
differ
assay
thu
studi
need
identifi
intestin
microbi
dynam
induc
porcin
fmt
effect
porcin
fmt
becom
visibl
fecal
microbiota
transplant
wide
use
human
therapi
gastrointestin
diseas
includ
cdi
ibd
ib
interestingli
recent
studi
use
fmt
restor
phenotyp
donor
recipi
suggest
key
role
intestin
microbiota
mammalian
host
health
obes
ridaura
et
al
goodrich
et
al
colon
cancer
wong
et
al
pathogen
resist
lawley
et
al
antitumor
immun
sivan
et
al
thu
character
porcin
intestin
microbi
function
via
fmt
great
signific
requir
investig
underli
mechan
fmt
gut
microb
confer
efficaci
fmt
still
unclear
thu
precis
manipul
gut
microbiota
probiot
benign
microb
current
emerg
promis
therapeut
strategi
gastrointestin
disord
foxxorenstein
chey
lawley
et
al
buffi
et
al
schieber
et
al
recent
develop
highthroughput
approach
includ
metagenom
metatranscriptom
metabolom
appli
identifi
associ
host
health
composit
function
gut
microbiota
koott
et
al
costea
et
al
studi
identifi
specif
intestin
microbi
candid
specif
diseas
pathogenesi
provid
novel
therapeut
strategi
take
advantag
benefici
microb
everard
et
al
jh
lc
wrote
paper
help
author
jh
lc
yt
cx
bx
ms
wz
sz
xw
yy
ty
yn
qh
xx
prepar
materi
manuscript
xy
revis
manuscript
author
read
approv
final
version
manuscript
thank
present
past
member
yan
laboratori
contribut
comment
idea
